Beam Therapeutics BEAM Current ratio

Current ratio at other companies

Vertex PharmaceuticalsVRTX

3.2×+0.7×

Arrowhead ResearchARWR

6.2×+1.1×

Ultragenyx PharmaceuticalRARE

1.7×-0.7×

MGN

MagniteMGNI

1×0.0×

Wave Life SciencesWVE

10×+7.4×

Intellia TherapeuticsNTLA

6.6×+1.5×

FAQ

What is Beam Therapeutics's current ratio?

Beam Therapeutics (BEAM) reported current ratio of 17× in Q1 2026.

How has Beam Therapeutics's current ratio changed year-over-year?

Beam Therapeutics's current ratio increased by 92.8% year-over-year, from 8.8× to 17×.

What is the long-term trend for Beam Therapeutics's current ratio?

Over 5 years (2020 to 2025), Beam Therapeutics's current ratio has grown at a 34.1% compound annual growth rate (CAGR), from 3× to 13.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.